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Background: Respiratory illnesses are common among pediatric patients in Kenya, and many are attributed to viral 
causes. However, there is limited knowledge of the diversity of viral etiologies associated with these illnesses.  
Objective: To characterize respiratory adenoviruses isolates using serological and molecular approaches. 
Methods: A total of 1,879 samples were collected from symptomatic pediatric patients seeking medical care at New 
Nyanza Provincial General Hospital during the period of June 2010 to June 2012 and screened for adenoviruses as 
well as other respiratory viruses. Sixteen respiratory human adenoviruses (HAdVs) were isolated in Hep2 cell culture 
and characterized them using Immunofluorescence Assay, viral DNA amplification, sequencing and phylogenomics.  
Results: Phylogenetic characterization of the HAdVs using the hyper variable region 7 of the hexon gene identified 
HAdV B and C as the major species associated with respiratory infections during the study period. Amongst these, a 
single B-type and four C-type serotypes were identified.  The serotype distribution consisted of 31% HAdV B7, 25% 
HAdV C1, 25% HAdV C2, 6% HAdV C5, and 13% HAdV C6. Positive selection was observed in the nucleotide 
sequences from HAdV B7 and HAdV C5 signaling evolution of these two serotypes.   
Conclusion: These finding may be useful to policy makers regarding appropriate strain selection for vaccination in 
Kenya. 
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1. Introduction 
Adenovirus is a double stranded DNA virus first isolated 
in 1953  from adenoid tissue–derived cell cultures 
(Enders et al, 1956). Human adenovirus (HAdV) belongs 
to the genus Mastadenovirus in the Adenoviridae family. 
It is a non-enveloped virus with an icosahedral structure 
and a genome size of between 26-45kb. Currently, there 
are 60 known serotypes of HAdVs which are grouped 
into seven species A-G (Robinson et al, 2013; Walsh et al, 
2010). Species B, C and E are associated with 
approximately 10 % of pediatrics respiratory illnesses 
globally, whereas the other species are associated with 
gastrointestinal, genitourinary and ocular infections 
(Sharma et al, 2009; Tebruegge and Curtis, 2012). 
Amongst adults, respiratory adenoviruses have been a 
serious concern in military training camps and are major 
cause of morbidity and have occasionally been 
associated with mortality (Potter et al, 2012). 
Each species of adenovirus is associated with different 
spectra of diseases and severity of infection, therefore, 
rapid identification of a particular virulent serotype can 
help in prevention and disease management strategies. 
Initially, diagnosis and determination of adenovirus type 
involved virus isolation in cell culture followed by 
antibody/antigen detection by immunofluorescence or 
neutralization assays. However, molecular methods have 
replaced these serological approaches of detecting and 
serotyping adenoviruses (Madisch et al, 2005; Sarantis et 
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al, 2004). The molecular approaches are rapid and 
specific in detection and classification of adenoviruses 
(Madisch et al, 2005). These methods are based on the 
nucleotide sequencing of adenovirus genome followed 
by bioinformatics analysis of the sequences (Madisch et 
al, 2005).  
Here, we used the adenovirus classification scheme 
reported by (Madisch et al, 2005) together with the 
method described by (Sarantis et al, 2004) to 
molecularly identify species and serotypes of respiratory 
human adenoviruses isolates from pediatric patients in 
western Kenya.  We show the serotype diversity of these 
viruses in Kenya and that two species, B and C, 
represented by five serotypes predominated during the 
study period. 
2. Materials and Methods 
2.1 Study population and case definition 
We used previously collected and archived 
nasopharyngeal specimens (Bulimo et al, 2008).  The 
study population comprised persons from two months to 
17 years presenting with influenza like illnesses (ILI) to 
the New Nyanza Provincial General Hospital.  The ILI 
cases were identified according to the WHO manual for 
influenza surveillance (W. WHO, 2013).   Briefly, the case 
definition included patients presenting with cough and 
fever of above 380C within 3 days prior to onset of illness. 
2.2 Virus stocks, cell cultures and viral DNA 
extraction 
We studied HAdV isolated from nasopharyngeal swab 
specimens from an ongoing influenza virus surveillance 
program at the United States Army Medical Research 
Unit – Kenya (Bulimo et al, 2008). The isolates were 
obtained from symptomatic pediatric patients seeking 
medical care at New Nyanza Provincial General Hospital 
located in the western part of Kenya during the period of 
June 2010 to June 2012. During this period, a total of 
1,879 samples were collected and screened for 
adenoviruses as well as other respiratory viruses. The 
viruses were isolated and archived at -80oC prior to 
serological and molecular characterization.   
Serological characterization was carried out using a 
HAdV-specific fluorescent monoclonal antibody (DFA) 
kit (Millipore, Temecula, CA, 92590, USA) according to 
the manufacturer’s instructions. Prior to molecular 
characterization, viral genomes were extracted from 200 
µl of infected cell lysate using a QIAamp Viral DNA mini 
kit (Qiagen, Valencia CA, USA) according to the 
manufacturer’s instructions. Extracted viral DNAs were 
re-suspended in 100 µl elution buffer and stored at -80oC 
until use. 
2.3 PCR and sequencing 
We used a molecular typing scheme based on PCR 
amplification and sequencing of portions of hexon 
epsilon determinant loop-2 region (Madisch et al, 2005). 
The loop-2 fragment of hexon gene was amplified using 
primers pair described previously (Sarantis et al, 2004). 
The forward primer sequence was 5’-GCG TTG CGG TGG 
TGG TTA AAT GGG TTT ACG TTG TCC AT-3’ while the 
reverse primer sequence was 5’-CTG ATG TAC TAC AAC 
AGC ACT GGC AAC ATG GG-3’. These primers flank the 
hyper-variable region 7 (HVR-7) of loop-2 of the hexon 
gene and yield PCR products ranging in size from 510 to 
530bp depending on the HAdV serotype and species. 
PCR amplification was performed in a 50µl reaction 
volume containing 1X PCR Buffer, 3µM MgSO4, 200µM 
concentrations of each deoxynucleotide triphosphate, 
0.5µM concentrations of each primer, 2.5U of high 
fidelity Taq DNA polymerase (all reagents from 
Invitrogen, Carlsbad CA, 92008 USA), and 5µl of DNA 
template. Gene Amp PCR Systems 9700 Thermo cycler 
(Life Technologies, Grand Island, NY, USA) was used with 
the following settings: an initial denaturation at 94°C for 
2 minutes, followed by 30 cycles of denaturation at 94°C 
for 1 minute, annealing at 54°C for 1 minute, and 
elongation step at 72°C for 3 minutes, with a final 
extension at 72°C for 7 minutes. Virus amplicons were 
separated using 1% agarose gel electrophoresis and 
visualized under UV light by staining with ethidium 
bromide (0.5μg/ml).  
Following amplification, PCR products were purified 
using the ExoSAP-IT method according to the 
manufacturer’s instruction (Affymetrix, Inc. USA). 
Bidirectional sequencing was performed using the 
amplification primers and the Terminator Cycle 
Sequencing Ready Reaction Kit version 3.1 (Applied 
Biosystems, Carlsbad CA, USA), prior to running on the 
3500xL Genetic analyzer (Applied Biosystems, Carlsbad 
CA, USA). Nucleotide sequence contigs were assembled 
and edited using DNA Baser Sequence Assembler version 
10 (Heracle BioSoft, Pitesti, Romania) available at 
http://www.dnabaser.com.  
2.4 Bioinformatics analyses 
The assembled nucleotide sequences were used to query 
for similar sequences in the GenBank non-redundant 
nucleotide sequences database using BLAST (Altschul et 
al, 1997).  The GenBank nucleotide sequences displaying 
the highest sequence identities to each of the sixteen 
HAdV sequences as well as reference hexon sequences 
representing each serotype of respiratory human 
adenovirus were retrieved from GenBank for multiple 
sequence alignment and inference of phylogeny. The 
sequences identified had accession numbers 
KC747631.1, AF515814.1, HQ535662.1, AF053085.1, 
AB436561.1, FJ943599.1, KC747641.1, JQ407712.1, 
AJ293903.1, AY008279.1, KC689915.1, KC551973.1, 
AB330115.1, AB330116.1, AB330131.1, AB330097.1, 
AB330095.1, AB330092.1, AB330088.1, AB330087.1, 
AB330086.1, AB330085.1, AB330084.1, 
AB330082.1.and  K01264.1.  K01264.1 is a bovine 
adenovirus 3 sequence and was used as the out group in 
the phylogenetic analyses.  
Multiple sequence alignment was perfomed using 
Muscle version 3.8.3.1 (Edgar, 2004) and edited and 
visualised by GeneDoc version 2.6.002 (Nicholas and 
Nicholas, 1997). Phylogenetic analysis was perfomed 
using Bayesian inference of phylogeny executed in 
MrBayes version 3.2.2 (Huelsenbeck and Ronquist, 
2001). The General Time reversible (GTR) model 
(Tavare, 1986) with gamma distributed rate variation 
across site and a proportion of invariable sites was used. 
For phylogenetic reconstruction, 1,000,000 Markov 
chain Monte Carclo (MCMC) generations were 
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performed with a sampling frequency after every 1000 
trees. The results of phylogenetic analyses were 
visualized with Figtree version 1.4.0 (Rambaut, 2007). 
Synonymous and nonsynonymous mutations were 
calculated using MEGA version 5.2 (Tamura et al, 2011). 
The analysis involved computation of the overall mean 
distance in a set of aligned sequences of the same 
serotype together with corresponding reference 
sequences. Two substitution models were used 
separately for comparison purpose; the Nei-Gojobori 
(Jukes-cantor) and the Kumar (Kimura-2-parameter) 
methods. Nonsynonymous-synonymous ratio (dN/dS) of 
<1 for sequences of the same serotype was used to imply 
a purifying selection of the sequences. Likewise dN/dS 
ratio of >1 implied that the sequences were under a 
positive selection pressure. 
2.5 Ethical considerations 
Informed consents were obtained from parents or 
guardians of children involved in the study. Adults >18 
years consented for themselves.  The subjects also 
consented that samples collected from them or their 
children could be stored and be used for other 
subsequent studies. Two ethical review boards, the 
Walter Reed Army Institute of Research (WRAIR) 
Institutional Review Board (IRB) and the Kenya Medical 
Research Institute (KEMRI) Ethics Review Committee 
(ERC) approved this study and consent procedure under 
protocol WRAIR#2014 and KEMRI SSC#2499 
respectively.  The informed consent process covered the 
archiving and use of samples for future molecular 
studies. 
3.  Results  
Clinical picture of patients infected with HAdVs 
All the patients infected with HAdV presented with fever 
and cough. Other symptoms associated with infection 
with HAdV included nasal stuffiness (63 %), runny nose 
(56 %), chills (25%) and vomiting (19 %).  Malaise (13 
%), sore throat (13 %) headache (6 %) and retro-orbital 
pain (6 %) were reported less frequently (Figure 1). 
Figure1. Summary of % distribution of presenting symptoms of pediatric patients with human adenovirus infection 
during the period of June 2010- June 2012 
Serological and nucleotide sequences analysis  
In the period of June 2010 to June 2012, 1879 
nasopharyngeal swab specimens from symptomatic 
patients were collected from New Nyanza Provincial 
General Hospital through the influenza surveillance 
program at USAMRU-K.  Serological examination of 
patient’s samples revealed 16 HAdV cases amongst 
these. BLAST analyses for the isolated nucleotide 
sequences revealed that the sixteen sequences had very 
high similarities to human adenovirus with expectation 
(E) values of zero and nucleotide identities of 98-99% 
compared to the next homologous reference sequence in 
the GenBank database. 
Phylogenetic analyses 
Phylogenetic reconstruction of the sixteen HAdV based 
on reference sequences from respiratory HAdV species 
B, C and E yielded the phylogentic tree shown in Figure 
2. The sequences grouped into two main genetic clusters 
belonging to HAdV B and C species. Six sequences 
(isolate 02, isolate 05, isolate 06, isolate 11, isolate 13, 
and isolate 14,) clustered among the HAdV B7  reference 
serotypes while the remaining ten clustered with HAdV 
C reference serotypes. The grouping in the HAdV C 
genetic clusters further segregated into four distinct 
clades  representing serotype 1 (isolate 01, isolate 08, 
isolate 09) serotype 2 (isolate 07, isolate 10, isolate 15, 
isolate 16) serotype 5 (isolate 12) and serotype 6 (isolate 
03, isolate 04). Overall, the  HAdV distribution was HAdV 
C serotype 1 at 25%, HAdV C serotype 2 at 25%, HAdV C 
serotype 5 at 6%, and HAdV C serotype 6 at 13%. HAdV 
B serotype 7 accounted for 31% of the isolates. The 
nucleotide sequences from this study were deposited in 
GenBank database under the accession numbers:  
KJ527469 to KJ527484. 
Natural selection within Hexon loop2 
The synonymous (dS) and non-synonymous (dN) rates 
of nucleotide substitutions in the loop-2 sequences were 
used to evaluate natural selection amongst the viruses. 
Table 1 shows a summary of the dN/dS ratio as 
calculated following two substitution models; Nei-
Gojobori and Kumar substitution models (Kimura, 1980; 
Nei and Gojobori, 1986). Sequences in the HAdV C 
serotype 1 and serotype 6 gene clusters had dN/dS ratio 
of 1. The dN/dS nucleotide substitutions ratio of HAdV 
species C serotype-2  genetic clusters was less than 1 
while in HAdV species C serotype 5 and HAdV species B 
serotype 7  was greater than 1. 
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4. Discussion 
HAdVs cause morbidity and mortality, especially in 
pediatric & immune compromised patients and in the 
military recruits living in close quarters (Potter et al, 
2012).  Specific HAdV serotypes are associated with 
distinct clinical conditions (Sharma et al, 2009) and 
therefore an understanding of HAdV serotypes 
circulating in a population is crucial in planning and 
management of the disease caused by these viruses and 
ensuring timely intervention, policy decision making and 
public health preparedness.  
Serological and molecular characterization of HAdV is 
important in understanding the epidemiology of the 
disease caused by this virus. Therefore, we sought to 
bridge the gap in the knowledge from a Kenyan context 
by systematically carrying out serological and molecular 
characterization of those 16 identified respiratory 
human adenoviruses. The 16 cases reported here show 
that the prevalence of respiratory HAdV at this hospital 
during the study period was approximately 1%.  This 
prevalence is very low compared to prevalence of 
infection by influenza viruses at the same hospital during 
the same time, which was approximately 25% (Kenyan 
National Influenza Centre laboratory reports).  
Furthermore, the prevalence of respiratory HAdV 
elsewhere ranges from 5-10% (Yan, 2014). Thus, 
respiratory disease burden at this hospital due to 
respiratory HAdV was very low.
Figure 2. Phylogenetic analysis using the nucleotide sequences of the ɛ determinant loop2 from HAdVs. Phylogeny was 
inferred by a Bayesian method and visualized using FigTree v1.4.0. Reference HAdV species B, C and E are identified 
with their GenBank accession numbers. Bovine Adenovirus 3 was used as an out-group. Sequences belonging to the 
same species or serotype clusters are highlighted with brackets. The posterior probability values are expressed as 
percentages on each branch. 
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 Kumar substitution 
models 
dS dN dN/dS  dS dN dN/dS 
HAdV C serotype 1 
genetic cluster 
0.2052 0.2746 1.0 
 
0.2291 0.2523 1. 0 
HAdV C serotype 2 
genetic cluster 
0.0208 0.0133 0.64 
 
0.0335 0.0136 0.4 
HAdV C serotype 5 
genetic cluster 
0.0067 0.0417 6.2 
 
0.0026 0.046 17.7 
HAdV C serotype 6 
genetic cluster 
0.0109 0.0118 1.0 
 
0.01 0.0109 1.0 
HAdV B serotype 7 
genetic cluster 
0.013 0.0283 2.2 
 
0.0185 0.0263 1.4 
 
The high sequence homology of isolated nucleotides 
sequences confirmed the serological results that indeed 
the virus stocks belonged to adenovirus group of viruses.  
Indeed, past studies have demonstrated that nucleotide 
sequence homology of more than 97.5% is a valid criteria 
for determining the identity of adenovirus isolates 
(Madisch et al, 2005).  
The Hexon epsilon fragment is one of the species and 
serotype-specific determinant regions in adenovirus 
genome. Other serotype-specific regions are found in the 
penton and fiber genes (Xu et al, 2000). Previous studies 
have demonstrated that analyzing either loop1 or loop2 
regions of hexon epsilon determinant can classify 
adenoviruses serotypes (Madisch et al, 2005). The Hexon 
loop2 region used in this study has been described as the 
most simple, yet sufficient approach for molecular typing 
of human adenoviruses (Madisch et al, 2005). Thus using 
the nucleotide sequences of loop-2 hyper-variable region 
7 (HVR 7) in a phylogenetic reconstruction analysis, the 
16 virus isolates clustered into distinct clades with high 
(100%) overall posterior probability values. The general 
overall high posterior probabilities values indicated that 
the viruses were adequately identified as belonging to a 
particular species or serotype. The posterior probability 
values were, however, low (e.g. 54%) at nodes 
separating putative strains of the same serotype, 
indicating that strain separation may be more difficult to 
achieve using molecular phylogenetic analyses.  
Phylogenetic analyses using the hexon loop-2 nucleotide 
sequences demonstrated that during the study period, 
HAdV C was the predominant species accounting for 
69% of the reported cases. During the study period, four 
serotypes of species C (i.e. serotypes C1, C2, C5 and C6) 
were identified in circulation. However, for HAdV B, only 
a single serotype 7 was identified.  Interestingly, despite 
being the only species B serotype in circulation during 
this period, HAdV 7 was the predominant serotype 
accounting for 31% of all isolates. The HAdV B serotype 
7 has been associated with outbreaks and in certain 
cases fatalities and therefore prevalence of this serotype 
in the Kenyan population has public health significance 
(Kim et al, 2003; O’Flanagan et al, 2011). Vaccination 
against HAdVs and in particular serotype 7 is therefore 
recommended.  
HAdV species E was not observed among the isolates, 
suggesting that this species was not in circulation during 
the study period. Previous studies have suggested that 
HAdV E might have emerged through recombination 
involving strains of HAdV B serotypes14 and 16 (Shenk, 
2001). Since only HAdV B7 serotype was observed 
amongst the Kenyan isolates during the study period, the 
absence of serotypes 14 and 16 may explain the absence 
of HAdV E among the Kenyan isolates. 
The dN/dS ratio amongst sequences constituting HAdV 
C1 and HAdV C6 genetic clusters had a value = 1, showing 
that those viruses were not under any selection pressure. 
The HAdV C2 genetic cluster yielded dN/dS ratio of less 
than 1 indicating the sequences were under a purifying 
selection pressure. This means that from an evolutionary 
perspective HAdV C2 have interacted with the human 
host for long and are probably an old serotype.  The 
dN/dS ratio of sequences constituting the HAdV C5 and 
HAdV B7 genetic clusters was greater than 1 implying 
that these sequences were under positive selection 
pressure and that these two are the most recently 
emerged serotypes and are expected to be more virulent.   
Normally genes exhibiting positive selection pressure 
indicate that the organism is continually undergoing 
evolution in order to adapt to changes in the 
environment. Consequently, the Kenyan HAdV C5 and 
HAdV B7 were found to be undergoing an evolutionary 
process which signifies instability in their genomes. 
HAdV B7 was also the predominant serotype circulating 
during the study period. These serotypes are of great 
significance from a clinical perspective. Both HAdV B7 
and HAdV C5 serotypes have been implicated in 
adenovirus outbreaks and in some cases fatalities (Kim 
et al, 2003; O’Flanagan et al, 2011; Seto et al, 2010) while 
HAdV C5 was a vaccine vector for Prime Boost HIV 
vaccine that was tested in clinical trials in Kenya 
(Kibuuka et al, 2010). Positive selection pressure 
occurring in Kenyan HAdV C5 leading to an activated 
immune response may explain the failure of the Prime 
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Boost HIV vaccine in Kenya.   In future, HAdV C5 vectored 
vaccines may not be appropriate for Kenya.   
There is need to continually carry out surveillance of 
these adenovirus serotypes in order to track their 
evolution. Drastic evolution of these serotypes could 
eventually result in emergence of more virulent 
adenoviruses which can be difficult to manage in case of 
severe outbreaks. Policy makers in the Kenyan health 
sector may do well to consider introducing the 
adenovirus vaccine currently used by the US military to 
the Kenyan population especially among the most 
vulnerable in the general population like respiratory 
disease pediatric patients in wards and military recruits 
living in close quarters. The adenovirus vaccine used by 
the US military is a divalent vaccine with components of 
B7 and B14 serotypes.  A Kenyan specific vaccine should, 
perhaps, include the C5 component.  Adenovirus 
vaccination programs have been successful in reducing 
the prevalence of adenovirus infections in other parts of 
the world (Potter et al, 2012) and therefore such efforts 
would be prudent in Kenya. 
Whereas this work has contributed to closing the 
knowledge gap that existed regarding some molecular 
characteristics of respiratory human adenoviruses found 
in Kenya, like most studies, it has limitations.  For 
example, only one of the three diagnostically useful 
genes in detection and genotyping of adenoviruses, the 
hexon gene, was used. Further studies utilizing 
nucleotide sequences of the penton and fiber genes, 
preferably full-length genes and even better full genome 
sequences of the adenoviruses will afford a more 
comprehensive picture of the genetic characteristics and 
serotype diversity of the Kenyan respiratory human 
adenoviruses.  Additionally, since adenovirus was such 
an uncommon cause of ILI in the population under study, 
the number of specimens available for genetic analysis 
was low and may not represent a complete picture of 
diversity of these viruses in Kenya. 
In conclusion, we have identified and classified 
respiratory human adenoviruses using the HVR 7 region 
of Hexon gene for the first time in Kenya. 
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